Novo Integrated Sciences Inc
NASDAQ:NVOS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Novo Integrated Sciences Inc
Net Issuance of Debt
Novo Integrated Sciences Inc
Net Issuance of Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Novo Integrated Sciences Inc
NASDAQ:NVOS
|
Net Issuance of Debt
-$3.9m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Net Issuance of Debt
-$218m
|
CAGR 3-Years
-502%
|
CAGR 5-Years
-113%
|
CAGR 10-Years
12%
|
|
|
CVS Health Corp
NYSE:CVS
|
Net Issuance of Debt
-$1.8B
|
CAGR 3-Years
25%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Net Issuance of Debt
-$667m
|
CAGR 3-Years
36%
|
CAGR 5-Years
32%
|
CAGR 10-Years
-26%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Net Issuance of Debt
-$1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Net Issuance of Debt
$402.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
Novo Integrated Sciences Inc
Glance View
Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 113 full-time employees. The company went IPO on 2005-07-12. The company owns Canadian and United States subsidiaries, which provide solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutics, personalized product offerings, and rehabilitative science. Its Canadian subsidiary, Novo Healthnet Limited, provides its services and products through both clinic and eldercare related operations. The company has two segments: healthcare services, and product manufacturing and development. Its primary care services include physiotherapy, chiropractic care, occupational therapy, eldercare, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury, kinesiology, vestibular therapy, and others. The company also provides global consulting specialized in providing value-added services for pharmaceutical, biotech, healthcare, hospital, medical, others.
See Also
What is Novo Integrated Sciences Inc's Net Issuance of Debt?
Net Issuance of Debt
-3.9m
USD
Based on the financial report for Aug 31, 2024, Novo Integrated Sciences Inc's Net Issuance of Debt amounts to -3.9m USD.
What is Novo Integrated Sciences Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 3Y
-9%
Over the last year, the Net Issuance of Debt growth was -36%. The average annual Net Issuance of Debt growth rates for Novo Integrated Sciences Inc have been -9% over the past three years .
